Avantor, Inc. (NYSE:AVTR) Shares Acquired by Diversify Wealth Management LLC

Diversify Wealth Management LLC grew its holdings in Avantor, Inc. (NYSE:AVTR) by 10.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 41,069 shares of the company’s stock after acquiring an additional 3,722 shares during the quarter. Diversify Wealth Management LLC’s holdings in Avantor were worth $890,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Kera Capital Partners Inc. acquired a new stake in shares of Avantor during the fourth quarter worth about $393,000. Wedge Capital Management L L P NC lifted its position in Avantor by 2.6% during the 4th quarter. Wedge Capital Management L L P NC now owns 66,068 shares of the company’s stock worth $1,392,000 after acquiring an additional 1,677 shares during the period. Avanza Fonder AB purchased a new position in shares of Avantor in the 4th quarter valued at approximately $1,368,000. Legacy Wealth Asset Management LLC raised its stake in shares of Avantor by 6.5% during the fourth quarter. Legacy Wealth Asset Management LLC now owns 24,363 shares of the company’s stock worth $513,000 after purchasing an additional 1,496 shares during the last quarter. Finally, CCLA Investment Management increased its stake in Avantor by 4.5% in the 4th quarter. CCLA Investment Management now owns 5,357,703 shares of the company’s stock valued at $112,940,000 after buying an additional 229,199 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on AVTR shares. Barclays reduced their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, October 25th. Royal Bank of Canada restated an “outperform” rating and issued a $34.00 price target on shares of Avantor in a research note on Thursday, September 26th. UBS Group reiterated a “neutral” rating and issued a $25.00 price objective (down previously from $29.00) on shares of Avantor in a research report on Friday, January 17th. Robert W. Baird lowered their price target on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research note on Monday, October 28th. Finally, Raymond James reduced their price objective on shares of Avantor from $29.00 to $26.00 and set an “outperform” rating for the company in a research note on Tuesday. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $27.38.

Avantor Stock Performance

Avantor stock opened at $21.74 on Wednesday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54. Avantor, Inc. has a fifty-two week low of $19.59 and a fifty-two week high of $28.00. The stock has a fifty day moving average of $21.45 and a two-hundred day moving average of $23.40. The company has a market capitalization of $14.79 billion, a price-to-earnings ratio of 47.25, a PEG ratio of 3.51 and a beta of 1.28.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.